Taken together these results indicate that the functional axis identified in this study, and linking NFATc2 to EZH2, is not only a relevant regulatory network of the EMT-like program in melanoma cells, but also a potential actionable pathway in different subsets of melanomas, irrespective of BRAF/NRAS mutational status. This evidence concerns the gene NFATC2 and melanoma.